...
首页> 外文期刊>Neurosurgery >Giant aneurysm clipping under protection of an excimer laser-assisted non-occlusive anastomosis bypass.
【24h】

Giant aneurysm clipping under protection of an excimer laser-assisted non-occlusive anastomosis bypass.

机译:在受激准分子激光辅助的非闭合性吻合旁路的保护下进行的大动脉瘤夹闭术。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To define the safety and clinical value of giant aneurysm clipping under protection of an excimer laser-assisted non-occlusive anastomosis (ELANA) bypass. METHODS: We report 32 patients with an uncoilable intracerebral giant aneurysm, operated on with the aid of an ELANA protective bypass between January 1, 1994, and January 1, 2008. We retrospectively collected data from patient records. Follow-up data were updated by telephone interview. We defined a favorable outcome as a successfully treated aneurysm and a better or equal postoperative modified Rankin scale (mRS) score compared with the preoperative mRS. RESULTS: In total 33 bypasses were constructed, of which 31 (94%) were patent during the rest of the procedure. The first failed bypass was salvaged during a second procedure. Of the second failed bypass, the ELANA anastomosis could be reused during second bypass surgery. All 32 aneurysms could be treated. The bypasses served as protection during temporary parent vessel occlusion (n = 24, 75%), control during aneurysm rupture (n = 3, 9%), and in all patients as an indicator for recipient artery narrowing during clip placement. Four bypasses (12%) eventually had to partially (n = 3) or fully (n = 1) replace recipient artery flow at the end of surgery. Postoperatively, 3 patients (9%) had a hemorrhagic complication and 2 patients (6%) had an ischemic complication. At long-term follow-up (mean, 6.1 +/- 3.4 y), 28 patients (88%) had a favorable functional outcome. CONCLUSION: The ELANA protective bypass is a safe and useful instrument for the treatment of these difficult aneurysms.
机译:目的:定义在准分子激光辅助的非闭塞性吻合术(ELANA)旁路保护下的巨大动脉瘤夹闭术的安全性和临床价值。方法:我们报告了1994年1月1日至2008年1月1日之间通过ELANA保护性旁路手术的32例不可治愈的脑巨大动脉瘤患者。我们从患者记录中回顾性收集了数据。随访数据通过电话采访进行了更新。我们定义了一个良好的结局,即与术前mRS相比,成功治疗的动脉瘤和术后改良的Rankin量表(mRS)评分更好或相等。结果:总共建造了33条旁路,其中31条(94%)在该程序的其余部分中获得专利。在第二个过程中挽救了第一个失败的旁路。在第二次失败的旁路手术中,可以在第二次旁路手术期间再次使用ELANA吻合术。所有32个动脉瘤均可治疗。旁路在暂时性父母血管闭塞时(n = 24,75%),动脉瘤破裂期间的对照(n = 3,9%)起到保护作用,并且在所有患者中均作为夹子放置期间受体动脉变窄的指标。在手术结束时,四次旁路(12%)最终不得不部分(n = 3)或完全(n = 1)替代受体动脉血流。术后3例(9%)发生出血并发症,2例(6%)发生缺血性并发症。长期随访(平均6.1 +/- 3.4 y)时,有28例患者(88%)的功能预后良好。结论:ELANA保护性旁路是治疗这些困难的动脉瘤的安全和有用的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号